Health innovations and valorization
Making healthcare more efficient, so that it contributes to a better quality of life, requires new products and services. That is why TU/e is developing new technologies to make care more patient-oriented. TU/e collaborates with a wide variety of industrial and medical partners to help achieve this goal.
TU/e is firmly embedded in a number of regional networks within the Brainport region. For example, we helped develop the Brainport Health Innovation program together with the healthcare sector, knowledge institutes, the business community, and government agencies. This program focuses on e-files, telehealth, new learning, and electronic communication diagnoses. In another network we are involved in, the Netwerk Slimmer Leven 2020, assisted living and wellbeing are the central topics, and education, research, and valorization all play an important role in achieving our goal. The validated solutions we devise are tested in the real world.
On another front, TU/e also collaborates with small and mid-sized businesses in the Brainport region to help start up new activities in the field of remote diagnostics and remote care using so-called living labs.
On a national level, TU/e has joined forces with Utrecht University and the University Medical Center Utrecht to help set up the joint research facility Institute for Diagnostic and Interventional Imaging (IDII).
Furthermore, TU/e actively participates in the nine Dutch top sectors, three of which are related to the field of health: Life Sciences & Health, High-Tech Systems and Materials and Creative Industries. TU/e actively participates in molding these sectors.
On an international level, TU/e is active in research programs and projects organized by the European Framework Program for Research. TU/e participates in the European EIT KIC ICT Health & Wellbeing program and is currently helping to prepare a new EIT KIC Health Technology program.
New businesses are frequently born at TU/e. QTIS/e is one of the latest TU/e spin-offs which develops heart valves using human body tissue. One great advantage of these heart valves is that they do not cause rejection symptoms in the body, which means the patient does not need to take additional medication.
Furthermore, the heart valves have the ability to grow with the body, which has great advantages for children, in particular, who no longer need repeated operations to replace the implanted valves as they age. QTIS/e continues to translate the results of its research into specific clinical applications.